Sequential therapy for H. pylori: an 'aberrant' therapy ready for general use.
Zullo
A
A
Hassan
C
C
Morini
S
S
De Francesco
V
V
Ierardi
E
E
Panella
C
C
Gatta
L
L
Vaira
D
D
D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D001729:Bismuth / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D011899:Ranitidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D000897:Anti-Ulcer Agents; C073340:ranitidine bismuth citrate; D011899:Ranitidine; D001729:Bismuth